Commercial Director
in health
How a Commercial Director turns a health or life-sciences product into durable revenue and the honest UK salary bands behind the title.
A Commercial Director is the senior leader accountable for turning a health or life-sciences product or service into a sustainable business. In practice that means owning how revenue is created and protected: which customers to pursue, what outcomes the organisation promises, how it prices and contracts, and how it structures partnerships so that delivery and margin both survive. The settings differ a lot. It might be a diagnostics company selling lab services to NHS trusts and private hospital groups, a medical device maker opening new distribution, a contract research organisation (CRO) winning sponsor work, a pharma services business protecting a key account, or a digital health scale-up landing its first reference contracts. The constant is single-point ownership of the commercial number.
This role exists because health and life-sciences growth is rarely just sales. Buyers are cautious, procurement is formal, clinical and data risk are real, and value has to be evidenced over time rather than asserted in a pitch deck. A Commercial Director gives the organisation one accountable owner for commercial performance across those constraints, so it can win business responsibly, meet its obligations, and expand without building hidden operational or regulatory debt.
In most organisations the role sits at the top of the commercial function and is measured on outcomes: revenue and margin, pipeline quality, win rates, the size and durability of strategic contracts, and the renewals that prove customers stayed. The methods change by setting, but the mandate does not. Bring in the right customers, on terms the business can honour, in a way that keeps delivery, compliance and reputation intact.
How this role differs in health and life sciences
In many tech sectors commercial strategy can optimise for speed: quick iterations, rapid expansion, and aggressive discounting to take share. Health and life sciences changes the equation. Decisions are shaped by higher perceived risk, longer evaluation cycles, stricter contracting, and the reputational cost of getting it wrong, because the product often touches patient pathways, clinical operations, regulated manufacturing, or sensitive data.
As a result, a Commercial Director here is usually closer to governance than a counterpart in consumer tech, and closer to delivery realities than a counterpart in pure-play SaaS. Selling into an NHS trust means a deal has to survive clinical sign-off, an information governance review against the Data Security and Protection Toolkit, and a procurement route through a framework that stands up to scrutiny, with CQC ratings and NICE guidance often sitting behind the customer's own pressures. Selling pharma or CRO services means respecting how the ABPI Code and Good Clinical Practice (GCP) shape what can be claimed and promised. Selling for a device or diagnostics maker means the commercial story cannot outrun the quality bar the business answers to, from MHRA oversight to ISO 13485. The job is less about optimism and more about precision: setting expectations the organisation can actually meet, then defending them through disciplined contracting and lifecycle management.
Core responsibilities in health and life sciences
Day to day, the Commercial Director shapes demand into contracts the organisation can deliver without compromising outcomes, safety or trust. The work sits where market ambition meets operational truth, and most of it is decision-making under constraint:
- Decide which segments and settings are worth pursuing (NHS, private healthcare, pharma, CROs, device and diagnostics makers, scale-ups) and concentrate effort where the business has a genuine right to win.
- Own the deal structures the organisation can sustain, trading price against term, scope against risk, and a strategic reference account against phased milestones with clear acceptance criteria.
- Set pricing and packaging that match how customers actually budget and procure, while reflecting implementation load and ongoing service cost so margin survives the contract.
- Negotiate commercial terms with risk, information governance and delivery in the room, so service levels, data processing obligations and incident expectations are signed knowingly, not discovered later.
- Run the commercial rhythm: keep pipeline quality real, forecasting defensible, and growth plans inside the company's ability to onboard, support and retain customers.
- Protect delivery teams by translating their constraints (timelines, resourcing assumptions, scope boundaries) into commitments the customer can hold the business to.
- Build and lead the commercial team, set the operating cadence, and represent commercial risk and opportunity at board level.
In scaling environments much of the value is translation: turning executive ambition into frontline reality and making the hard calls early, so the organisation does not pay for them later in churn, disputes or stalled deployments.
Skills and competencies for health and life sciences
| Core skill | Health and life-sciences requirement | Reason or impact |
|---|---|---|
| Commercial ownership | Comfort owning outcomes across the full contract lifecycle including implementation, not just signed value | Prevents paper wins that fail in delivery and turn into churn, reputational harm or contract disputes |
| Contract and risk judgement | Ability to assess operational, data and service risk in contract terms and negotiate proportionate protections | Health contracts carry stronger assurance expectations; weak judgement creates unbounded liabilities or impossible SLAs |
| Value articulation | Framing benefit in terms that withstand scrutiny (outcomes, efficiency, adoption, pathway or trial impact) not generic ROI claims | Buyers need a defensible case; a weak one slows procurement and erodes stakeholder confidence |
| Stakeholder navigation | Managing multi-stakeholder buying groups with competing incentives across clinical, IG, procurement and finance | A healthcare yes rarely sits with one persona; misalignment stalls deals late or dilutes adoption after sign |
| Regulatory and governance fluency | Knowing where the ABPI Code, GCP, MHRA oversight, ISO 13485 or NHS information governance constrain what can be sold and how | Lets the team move fast without promising things the organisation cannot compliantly deliver |
| Forecasting discipline | Building forecasts on evidence and stage-gated proof rather than optimism or single-thread relationships | Long cycles and formal approvals make accurate forecasting harder and more important for hiring and cash planning |
| Pricing and packaging judgement | Designing pricing that fits customer budget structures, implementation intensity and ongoing service cost | Mispriced deals are amplified by onboarding and support load and are hard to repair in constrained settings |
| Ethical decision-making | Recognising when commercial pressure conflicts with appropriate use, safety expectations or patient trust | Credibility is the asset; short-term wins that erode trust are costly and slow to reverse |
Salary ranges in UK health and life sciences
Commercial Director pay tracks scope and accountability more than the title alone. The biggest drivers are the size and complexity of the revenue you own, the maturity of the go-to-market motion (startup build versus scale-up optimisation versus enterprise expansion), and the risk embedded in what you sell (implementation intensity, data sensitivity, clinical exposure and contract liability). Setting matters too. Established pharma, device and diagnostics businesses tend to pay more predictably, while venture-backed digital health weights base lighter and equity heavier. Location still moves the number, especially for leadership roles concentrated around London and the South East.
| Experience level | Estimated annual salary range | What drives compensation |
|---|---|---|
| Junior | London & South East: £45,000 to £60,000. Rest of UK: £40,000 to £55,000 | Supports commercial operations, bid work or account coverage; limited P&L exposure; smaller deals and lower risk ownership |
| Mid-level | London & South East: £60,000 to £85,000. Rest of UK: £55,000 to £78,000 | Manages meaningful accounts or a defined segment; begins owning renewals and expansion; greater responsibility for forecast and contract detail |
| Senior | London & South East: £85,000 to £115,000. Rest of UK: £75,000 to £105,000 | Owns larger deals and more complex buying groups; expected to use independent judgement on pricing terms and deal strategy |
| Lead | London & South East: £105,000 to £140,000. Rest of UK: £95,000 to £125,000 | Leads a function or a major region or segment; accountable for target delivery and team performance; more board-level reporting and commercial governance |
| Head / Director | London & South East: £130,000 to £180,000. Rest of UK: £115,000 to £160,000 | Full accountability for the commercial number across functions or a major line of business; complex contracting and delivery alignment; strategic partnerships and higher execution risk |
Sources: Reed.co.uk and Glassdoor UK Commercial Director listings, the EPM Scientific Commercial Life Sciences Salary Guide 2024/25, and published UK pharma and medical-device director benchmarks. Treat these as a guide; real offers move with employer, setting and specialism.
Add-ons depend on whether the role is measured like a revenue leader or a general executive. Many roles include a performance bonus tied to revenue, margin, bookings, renewals or a balanced scorecard. Equity is more common in venture-backed health businesses and can be a meaningful slice of total compensation where base is kept tighter to preserve runway. On-call is not standard for commercial leadership, though some organisations expect senior coverage for escalations on major accounts or contractual service events. Total compensation also rises with deal size, any commission or OTE structure, and the cost of failure: the more a business leans on a small number of high-stakes contracts, the more it pays for proven judgement.
Career pathways
Most Commercial Directors in this market do not start with the title; they accumulate ownership. Common entry points include B2B sales, account management, partnerships, consulting, market access, procurement-facing roles or commercial operations, often in an adjacent regulated sector before moving into health or life sciences. Early progression comes from becoming the person trusted to close complex deals without creating downstream problems. You do not just win contracts, you win contracts that deliver.
As responsibility grows, the work shifts from individual execution to system design. You move from owning accounts to owning a segment, then to shaping pricing, packaging and contracting standards, then to leading teams and setting the operating rhythm of forecasting, performance management and cross-functional alignment. The step into Head or Director scope is usually marked by being accountable for the commercial number end to end: making hard prioritisation calls, building a team that scales, and representing commercial risk and opportunity at executive level. From there the path can run to Chief Commercial Officer, General Manager or country lead, or into a broader executive seat.
FAQ
Do these roles own sales only, or the full revenue engine?
It depends on company stage. In smaller health and life-sciences businesses the Commercial Director often owns sales, partnerships and customer success outcomes, because the organisation needs one accountable owner for the whole revenue lifecycle. In larger pharma, device or diagnostics organisations the remit may narrow to a region, product line or set of strategic accounts.
What will interviews test beyond can you sell?
Expect deep probing on judgement: pricing trade-offs, contract risk, how you handle long procurement cycles, and how you protect delivery while still hitting targets. Candidates are evaluated on how they qualify opportunities, how they forecast with evidence, and how they structure deals that survive implementation and an audit trail.
If I am coming from SaaS or another sector, what is the biggest adjustment?
You will need to be more precise about delivery assumptions, assurance expectations and stakeholder complexity, because buyers test credibility harder and move more slowly. Showing you can work inside governance, build trust and still create momentum tends to land better than pure hunter energy. Learning where the ABPI Code, GCP, MHRA expectations or NHS information governance actually bite will shorten your ramp.
Find your next role
Ready to own growth across UK health and life sciences? Search Commercial Director roles on Meeveem and find a scope that matches your strengths.